{"id":"https://openalex.org/W2282391237","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","title":"A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors","display_name":"A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2282391237","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","mag":"2282391237"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.3576","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2282391237"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023283384","display_name":"Patricia A. Tang","orcid":"https://orcid.org/0000-0003-1497-8539","observed_orcids":["https://orcid.org/0000-0003-1497-8539"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Tang","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072712459","display_name":"Amit M. Oza","orcid":"https://orcid.org/0000-0002-9510-8641","observed_orcids":["https://orcid.org/0000-0002-9510-8641"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Oza","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064229873","display_name":"Carol A. Townsley","orcid":"https://orcid.org/0000-0001-7005-6163","observed_orcids":["https://orcid.org/0000-0001-7005-6163"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Townsley","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112863337","display_name":"Lilian L. Siu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Siu","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047689900","display_name":"Gregory R. Pond","orcid":"https://orcid.org/0000-0003-1033-0882","observed_orcids":["https://orcid.org/0000-0003-1033-0882"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Pond","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087296517","display_name":"P. Sarveswaran","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Sarveswaran","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113725365","display_name":"Sheila Webster","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Webster","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033174879","display_name":"James A. Zwiebel","orcid":"https://orcid.org/0000-0003-4455-8789","observed_orcids":["https://orcid.org/0000-0003-4455-8789"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Zwiebel","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015996833","display_name":"E. Chen","orcid":"https://orcid.org/0000-0001-6900-2707","observed_orcids":["https://orcid.org/0000-0001-6900-2707"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Chen","raw_affiliation_strings":["Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Margaret Phase II Consortium, Toronto, ON, Canada; CTEP National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"3576","last_page":"3576"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorinostat","display_name":"vorinostat","score":0.9990000128746033},{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8939999938011169},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8830000162124634},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8519999980926514},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9419999718666077},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.8840000033378601},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.4519999921321869},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.6650000214576721},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9120000004768372},{"id":"https://openalex.org/keywords/nasopharyngeal-carcinoma","display_name":"nasopharyngeal carcinoma","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8454476594924927},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.7597191333770752},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.7311676740646362},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7251874208450317},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.7015976905822754},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.631371259689331},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5535656213760376},{"id":"https://openalex.org/C2776262904","wikidata":"https://www.wikidata.org/wiki/Q905901","display_name":"Vorinostat","level":5,"score":0.46291452646255493},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4411937892436981},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40925630927085876},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.40528321266174316},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3912433087825775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37736475467681885},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.1890885829925537},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.3576","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3576","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4236706093","https://openalex.org/W2590799613","https://openalex.org/W2216234816","https://openalex.org/W2536848830","https://openalex.org/W2590935769","https://openalex.org/W4230758805","https://openalex.org/W2211793629","https://openalex.org/W2590082034","https://openalex.org/W2169409181","https://openalex.org/W2264597658"],"abstract_inverted_index":{"3576":[0],"Background:":[1],"VOR":[2,47,70,79,203,321,339],"(suberoylanilide":[3],"hydroxamic":[4],"acid;":[5],"SAHA)":[6],"is":[7,48,330],"a":[8,28,38,94],"small":[9],"molecule":[10],"inhibitor":[11],"of":[12,27,40,44,69,93,147,213,225,259,300,307,338],"histone":[13],"deacetylase":[14],"(HDAC)":[15],"that":[16],"binds":[17],"directly":[18],"to":[19,201,277,348],"the":[20,25,63],"enzyme\u2019s":[21],"active":[22,331],"site":[23],"in":[24,37,50,73,168,317,332],"presence":[26],"zinc":[29],"ion.":[30],"Aberrant":[31],"HDAC":[32],"activity":[33],"has":[34],"been":[35,103,115,151],"implicated":[36],"variety":[39],"cancers.":[41],"The":[42],"combination":[43,329],"5-fluorouracil":[45],"and":[46,62,71,110,141,183,189,206,216,248,265,279,303,309,322,327,340],"synergistic":[49],"preclinical":[51],"tumor":[52,288,334],"models.":[53],"Methods:":[54],"This":[55],"phase":[56,65],"I":[57],"study":[58,272],"evaluated":[59,104],"safety,":[60],"tolerability,":[61],"recommended":[64],"II":[66],"dose":[67,100,160,172,180,195],"(RPTD)":[68],"CAP":[72,85,207,323,341],"pts":[74,113],"with":[75,153,286],"advanced":[76],"solid":[77],"tumors.":[78,144],"was":[80,86,199,315],"administered":[81,87],"orally":[82,88],"daily":[83],"while":[84],"bid":[89],"on":[90,271],"days":[91],"1\u201314":[92],"21":[95],"d":[96],"cycle.":[97],"Results:":[98],"Three":[99],"levels":[101],"have":[102,114,150],"(VOR":[105],"(mg/d)/CAP":[106],"(mg/bid)):":[107],"300/750,":[108],"300/1,000":[109],"400/1,000.":[111],"Twenty-three":[112],"treated:":[116],"6M/17F,":[117],"median":[118,154],"age":[119],"59":[120],"(range":[121,157],"41\u201373),":[122],"ECOG":[123],"0:1:2":[124],"=":[125,132,155],"9:13:1,":[126],"prior":[127],"therapy":[128],"1:2:3":[129],"or":[130],"more":[131],"3:7:13.":[133],"Pts":[134],"had":[135,290],"colorectal":[136],"cancer":[137],"(n=6),":[138],"nasopharyngeal":[139],"(n=3)":[140],"various":[142,287],"other":[143],"A":[145],"total":[146],"104":[148],"cycles":[149],"administered,":[152],"2":[156,184],"1\u201315).":[158],"One":[159,268],"limiting":[161],"toxicity":[162],"(DLT)":[163],"(grade":[164,186],"3":[165,187,191,253,294],"diarrhea)":[166],"occurred":[167,193],"6":[169],"patients":[170,285],"at":[171,179,194,217],"level":[173,181,196],"1.":[174],"No":[175,344],"DLT":[176],"were":[177],"observed":[178],"2,":[182],"DLTs":[185],"fatigue":[188,227,263],"grade":[190,215,252],"nausea/vomiting)":[192],"3.":[197],"RPTD":[198],"determined":[200],"be":[202],"300":[204],"mg/d":[205],"1,000":[208],"mg/bid.":[209],"Most":[210],"common":[211],"toxicities":[212,254],"any":[214],"least":[218],"possibly":[219],"attributable":[220],"(n=22)":[221],"are:":[222],"thrombocytopenia":[223],"(59%":[224],"pts),":[226,260],"(55%),":[228,230],"nausea":[229],"vomiting":[231],"(50%),":[232],"hypoalbuminemia":[233],"(45%),":[234],"anemia":[235],"(41%),":[236,238,240],"diarrhea":[237,261],"anorexia":[239],"elevated":[241],"creatinine":[242],"(36%),":[243,245,247],"lymphopenia":[244,266],"hyponatremia":[246],"hyperglycemia":[249],"(36%).":[250],"Common":[251],"included:":[255],"hand-foot":[256],"syndrome":[257],"(23%":[258],"(14%),":[262,264],"(14%).":[267],"pt":[269],"died":[270],"from":[273,281],"ventricular":[274],"fibrillation":[275],"due":[276],"sotalol":[278],"hypocalcemia":[280],"pre-existing":[282],"hypoparathyroidism.":[283],"Five":[284],"types":[289],"PR":[291],"(2":[292,296],"confirmed,":[293],"unconfirmed)":[295],"nasopharyngeal,":[297],"1":[298],"each":[299],"ovarian,":[301],"endometrial":[302],"squamous":[304],"cell":[305],"carcinoma":[306],"head":[308],"neck).":[310],"In":[311],"addition,":[312],"disease":[313],"stabilization":[314],"seen":[316],"12":[318],"patients.":[319],"Conclusions:":[320],"are":[324,342],"well":[325],"tolerated,":[326],"this":[328],"several":[333],"types.":[335],"Further":[336],"evaluations":[337],"warranted.":[343],"significant":[345],"financial":[346],"relationships":[347],"disclose.":[349]},"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}
